Method of treatment for cardiovascular complications
AssigneeAstraZeneca AB
InventorsErling Bjerregaard Pedersen, Friedrich Luft, Anders Svensson, Faies Zannad
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an angiotensin II type 1 receptor antagonist in the manufacture of a medicament for the prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis. The invention further relates to a method for prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis, comprising administering to the patient a therapeutically effective amount of an angiotensin II type 1 receptor antagonist.
Claims20
A method for preventive treatment of cardiovascular complications encountered in a patient in need of dialysis, comprising administering to such a patient a therapeutically effective amount of an angiotensin II type 1 receptor antagonist.
A method for therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis, comprising administering to such a patient a therapeutically effective amount of an angiotensin II type 1 receptor antagonist.
Dependencies are inferred from the claim text.